TARDBP and amyotrophic lateral sclerosis: A substantial number is expressed in postmortem ALS and ALS/FTD tissue with TDP-43 loss, underlining their potential involvement in pathogenic mechanisms and/or utility as biomarkers of TDP-43 pathology.